Patient Support

Avalere Health analysts map the converging pressures reshaping the drug pricing and distribution landscape ahead of November.

TailorMed broadens patient support beyond copay help, adding five modules that link access, affordability and adherence across specialty medications.

In a Q&A, Traci Miller discusses the evolving role of hub services as well as their commercial value.

Laura Blair discusses what makes enrollment friction, and how the right balance of AI and human support can improve hub utilization and speed to therapy.

Laura Blair discusses how DTP models make manufacturers rethink traditional access and distribution strategies.

Manasi Salgaonkar examines how accurate class of trade research enables precise pricing, contract eligibility, and compliance.

Anthony Bianciella explains how rare disease brands lose patients because journey maps prioritize prescribing intent over the complex, unfamiliar logistics of post-diagnosis access.

Michael Oleksiw says loneliness and behavior gaps drive prescription drop-offs, making early, personalized support critical to adherence.

Traci Miller, senior director of Access and Patient Support at Cardinal Health Sonexus, explains how hub data helps pharma companies shift from reactive firefighting to proactive access optimization.

Pleio CEO Michael Oleksiw discusses how loneliness can affect GLP-1 patient adherence.

Digital tools are improving efficiency, but human engagement remains critical for patient support.

Corey Ford explains why the rise of biosimilars and specialty therapies requires a shift from universal support models to highly tailored strategies.

Nareda Mills explains why patient services teams are more than support, but strategic drivers for brands.

Tina Valbh explains how disengagement and patient abandonment reveal gaps in support programs.

Pharma can optimize DTP strategies by leveraging data on affordability and patient behavior.

Corey Ford, principal at Nuvera, explains how pharma is shifting focus from HCPs to patients in support programs and commercialization.

Nareda Mills, global president of Patient Solutions at Inizio Engage, discusses how patient services are measured and which metrics demonstrate value to leadership.

From KPI clarity to right-sized staffing, Kimberly Howard explains how to measure true FRM impact and build flexible models that adapt to market realities.

Fragmented handoffs and poor communication can leave patients navigating delays and confusion in prior authorization workflows.

Jordan Armstrong outlines how adaptable DTP programs can reduce barriers and accelerate patient access to therapy.

Kimberly Howard, senior manager of Field Reimbursement Services at CoverMyMeds, explains how aligning hubs and reimbursement teams improves patient support.

Tina Valbh, managing partner at PharmaKonnect and co-founder of Tina’s Warriors, discusses the biggest post therapy launch patient support gaps.

The FDA granted a rapid 55-day approval for J&J’s combination of teclistamab and daratumumab hyaluronidase-fihj for multiple myeloma treatment.

In today’s Pharma Pulse, Eli Lilly has launched the Employer Connect platform broadening access to Zepbound for U.S. workers, while Tandem Diabetes expands the reach of its Mobi insulin pump to Android smartphones.